AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020High efficacy after switching to integrase strand transfer inhibitors (INSTI) in PLWH with undetectable viremia and past virological failure and/or resistanceView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV DNA drug resistance genotyping, based on illumina sequencing, as decisional marker for cart opimisation in clinical practice: added value, gaps and future directionsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Factors associated with the emergence of resistance mutations in patients failing dual or triple-integrase inhibitors-based regimen in a French national surveyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Prevalence and evolution of transmitted HIV drug resistance in Belgium between 2013 and 2019View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020HIV TRACE vs phylogenetic analysis: unraveling transmission clusters in SpainView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Infection with subtype D adversely affects the live expectancy among people living with HIV – data from Northwestern PolandView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Characterization and Resistance Profile of “Unusual” Hepatitis C Virus (HCV) Subtypes in ItalyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Abstract Book - European Meeting on HIV & Hepatitis 2020View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Hepatotoxicity Among HIV-Positive Ukrainian Patients Receiving Different Regimens Of ARTView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020The Role Of Direct Antiviral Therapy With Paritaprevir/Ritonavir + Ombitasvir + Dasabuvir On Fibrosis In Patients With Chronic Hepatitis C And Advanced FibrosisView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Serum Lipid Profile In HIV-Infected Patients, Receiving Different Regimens Of ARTView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Endoscopic Pathological Changes In HIV-Positive Patients With Low CD4+ T- Lymphocyte ValuesView Abstract
